Activin A: a novel urinary biomarker of renal impairment in multiple myeloma

Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality. However, no useful biomarkers for early detection of renal damage in MM exist. Reports indicate that activin A, a multifunctional cytokine of the TGF-β superfamily, is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biosci Rep
Egile Nagusiak: Iriuchishima, Hirono, Maeshima, Akito, Takahashi, Shunsuke, Ishizaki, Takuma, Yokohama, Akihiko, Tsukamoto, Norifumi, Saitoh, Takayuki, Murakami, Hirokazu, Handa, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Portland Press Ltd. 2019
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542761/
https://ncbi.nlm.nih.gov/pubmed/31072919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190206
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak